the efficacy and tolerance of the new oral cephalosporin cefaclor was tested in 61 patients treated for a variety of moderate to severe ent infections which were not expected to undergo a spontaneous remission without antibacterial therapy .
C0007537
cefaclor
C0279516
antibacterial